The CSEA3 participated in the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI) Congress 2025, held in Jakarta, Indonesia, from October 9–12, 2025

CSEA3 was represented by leading European experts who contributed significantly to the scientific program:

– Marek Jutel delivered a keynote lecture on the value of allergen challenge tests in allergen immunotherapy.

– Ioana Agache presented on the role of epithelial barrier in holistic approach to allergic disease.

– Magdalena Zemelka-Wiacek discussed the burden of nanoplastics in allergy and asthma

During the congress, CSEA3 representatives met with Tonya Winders, President & CEO of the Global Allergy & Airways Patient Platform (GAAPP), to discuss ongoing and future collaborative projects focusing on patient engagement, education, and global strategies in allergy and asthma care. CSEA3 leadership also met with APAAACI Congress Chair Ruby Pawankar and many other KOL to explore further collaboration with this important organization.

CSEA3’s active participation at APAAACI 2025 underscores its commitment to scientific excellence, international collaboration, and patient-centered innovation in allergy and asthma management.